Skip to main content
Premium Trial:

Request an Annual Quote

Clinical Data Reports 94-Percent Increase in Fiscal Q1 Revenues, Though Profit Swings to Loss

NEW YORK (GenomeWeb News) – Clinical Data yesterday reported a 94-percent revenue increase for its fical first quarter of 2007 as last year's profit swung to a loss.
 
The company reported $24.8 million in revenues for the quarter ended June 30, up from $12.8 million during the same quarter a year ago.
 
Product revenue climbed 26 percent to $14 million, from $11.3 million in the prior year. Service revenue surged to $10.6 million from $1.5 million in the prior year.
 
Clinical Data’s R&D expenses for the quarter climbed to $3.2 million from $707,000 during the same period a year ago.
 
The company’s net income for the quarter swung to a loss of $6.2 million, compared to a profit of $407,000 in the year-ago period.
 
As of June 30, Clinical Data had $19 million in cash and cash equivalents.

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.